The cell surface marker detection market size has grown rapidly in recent years. It will grow from $6.39 billion in 2025 to $7.11 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing biomedical research activities, expansion of pharmaceutical drug discovery programs, rising use of flow cytometry in diagnostics, growing investments in life sciences research, wider availability of laboratory automation.
The cell surface marker detection market size is expected to see rapid growth in the next few years. It will grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising demand for single-cell analysis, expansion of translational research initiatives, growing use of ai-assisted cell analysis, increasing investments in advanced diagnostic laboratories. Major trends in the forecast period include increasing adoption of high-throughput flow cytometry systems, rising demand for advanced reagents and kits, growing use of automated cell analysis platforms, expansion of marker-based precision diagnostics, enhanced focus on multiparameter cell profiling.
The growing prevalence of oncology-related diseases is anticipated to drive the expansion of the cell surface marker detection market in the coming years. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body. Factors such as the increasing adoption of westernized lifestyles, unhealthy dietary patterns, frequent consumption of non-vegetarian food, rising chemical pollution, and insufficient physical activity have collectively contributed to the global rise in cancer cases. Cell surface marker detection plays a critical role in oncology by enabling point-of-care assessment of patient responses to various cancer therapies, thereby supporting more targeted treatment decisions and boosting demand for these technologies. For example, in February 2024, the World Health Organization, a Switzerland-based international body focused on global health policy and public health, projected that more than 35 million new cancer cases would occur by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. Therefore, the increasing incidence of oncology diseases is fueling the growth of the cell surface marker detection market.
Leading companies in the cell surface marker detection market are investing in advanced technologies, such as innovative fluorescent dyes and antibodies, to enhance multicolour flow cytometry capabilities, thereby improving the accuracy and efficiency of immunological research and diagnostics. Bio-Rad has expanded its StarBright Violet Dye series by adding 29 highly validated antibodies conjugated to various StarBright Violet Dyes, which enhances the detection and analysis of multiple cell surface markers in human and animal studies through multicolour flow cytometry. For instance, in May 2024, Bio-Rad Laboratories, Inc., a US-based company specializing in developing and manufacturing advanced technological products, launched three new StarBright Red Dyes: StarBright Red 715, 775, and 815. This expansion increases their existing portfolio of fluorescent dyes to a total of 32 options across multiple lasers, specifically tailored for conventional and full-spectrum flow cytometry applications. Furthermore, these dyes demonstrate minimal background interference compared to traditional cyanine tandem dyes and are stable enough to be fixed in formalin or alcohol-based fixatives without compromising signal integrity.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for $2.8 billion. This acquisition is intended to bolster Thermo Fisher Scientific's specialty diagnostics portfolio by improving innovative solutions for blood cancer diagnostics, with a focus on the early diagnosis and effective treatment of multiple myeloma. The Binding Site Group, based in the UK, specializes in researching, developing, manufacturing, and distributing tests for detecting cancers and immune disorders, including flow cytometry.
Major companies operating in the cell surface marker detection market are Thermo Fisher Scientific Inc, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Becton Dickinson and Company, BD Biosciences, Agilent Inc, Sigma-Aldrich, Qiagen NV, Abcam PLC, GenScript Biotech, BioLegend, Cell Signaling Technology Inc, Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Miltenyi Biotec, R&D Systems, Siemens Healthineers, F Hoffmann-La Roche Ltd, Sartorius, Sysmex Corporation, Nihon Kohden Corporation, Diasorin SpA, Janssen Diagnostics.
North America was the largest region in the cell surface marker detection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell surface marker detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cell surface marker detection market by increasing costs of imported flow cytometers, hematology analyzers, antibodies, reagents, and electronic components. Research institutions and diagnostic laboratories in North America and Europe are most affected due to dependence on imported analytical instruments, while Asia-Pacific faces higher reagent and equipment costs. These tariffs are increasing laboratory operating expenses and slowing equipment upgrades. At the same time, they are supporting regional manufacturing of reagents, local instrument assembly, and domestic innovation in analytical technologies.
The cell surface marker detection market research report is one of a series of new reports that provides cell surface marker detection market statistics, including cell surface marker detection industry global market size, regional shares, competitors with a cell surface marker detection market share, detailed cell surface marker detection market segments, market trends and opportunities, and any further data you may need to thrive in the cell surface marker detection industry. This cell surface marker detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell surface marker detection involves the classification of cells based on their markers, which are proteins expressed on the cell surface or carbohydrates linked to the cell membrane. These markers serve as unique identifiers for specific cell types, akin to fingerprints. This process is valuable for categorizing cells based on their distinct markers.
The primary products associated with cell surface marker detection include flow cytometry, hematology analyzers, and various reagents and kits. Flow cytometry is a laboratory test that analyzes the properties of cells or particles suspended in fluid. During the procedure, a sample is injected into a flow cytometer machine, and a computer can rapidly evaluate and process a large number of cells. Flow cytometry is commonly used to assess bone marrow, peripheral blood, and other bodily fluids, playing a crucial role in disease diagnosis, diseases identification, drug discovery research, and cytological academic research. These products are utilized by a range of entities, including pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, among others. They contribute significantly to advancements in medical research, diagnostics, and drug development.
The cell surface marker detection market consists of revenues earned by entities by providing cell surface marker detection services such as cell analysis, fluorescence-activated cell sorting (FACS) analysis, immunohistochemistry, blood test, Tbnk test. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell surface marker detection market also includes sales of kits, dyes, analyzers equipment which are used in providing cell surface marker detection services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cell surface marker detection market size is expected to see rapid growth in the next few years. It will grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising demand for single-cell analysis, expansion of translational research initiatives, growing use of ai-assisted cell analysis, increasing investments in advanced diagnostic laboratories. Major trends in the forecast period include increasing adoption of high-throughput flow cytometry systems, rising demand for advanced reagents and kits, growing use of automated cell analysis platforms, expansion of marker-based precision diagnostics, enhanced focus on multiparameter cell profiling.
The growing prevalence of oncology-related diseases is anticipated to drive the expansion of the cell surface marker detection market in the coming years. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body. Factors such as the increasing adoption of westernized lifestyles, unhealthy dietary patterns, frequent consumption of non-vegetarian food, rising chemical pollution, and insufficient physical activity have collectively contributed to the global rise in cancer cases. Cell surface marker detection plays a critical role in oncology by enabling point-of-care assessment of patient responses to various cancer therapies, thereby supporting more targeted treatment decisions and boosting demand for these technologies. For example, in February 2024, the World Health Organization, a Switzerland-based international body focused on global health policy and public health, projected that more than 35 million new cancer cases would occur by 2050, representing a 77% increase compared to the estimated 20 million cases reported in 2022. Therefore, the increasing incidence of oncology diseases is fueling the growth of the cell surface marker detection market.
Leading companies in the cell surface marker detection market are investing in advanced technologies, such as innovative fluorescent dyes and antibodies, to enhance multicolour flow cytometry capabilities, thereby improving the accuracy and efficiency of immunological research and diagnostics. Bio-Rad has expanded its StarBright Violet Dye series by adding 29 highly validated antibodies conjugated to various StarBright Violet Dyes, which enhances the detection and analysis of multiple cell surface markers in human and animal studies through multicolour flow cytometry. For instance, in May 2024, Bio-Rad Laboratories, Inc., a US-based company specializing in developing and manufacturing advanced technological products, launched three new StarBright Red Dyes: StarBright Red 715, 775, and 815. This expansion increases their existing portfolio of fluorescent dyes to a total of 32 options across multiple lasers, specifically tailored for conventional and full-spectrum flow cytometry applications. Furthermore, these dyes demonstrate minimal background interference compared to traditional cyanine tandem dyes and are stable enough to be fixed in formalin or alcohol-based fixatives without compromising signal integrity.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for $2.8 billion. This acquisition is intended to bolster Thermo Fisher Scientific's specialty diagnostics portfolio by improving innovative solutions for blood cancer diagnostics, with a focus on the early diagnosis and effective treatment of multiple myeloma. The Binding Site Group, based in the UK, specializes in researching, developing, manufacturing, and distributing tests for detecting cancers and immune disorders, including flow cytometry.
Major companies operating in the cell surface marker detection market are Thermo Fisher Scientific Inc, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Becton Dickinson and Company, BD Biosciences, Agilent Inc, Sigma-Aldrich, Qiagen NV, Abcam PLC, GenScript Biotech, BioLegend, Cell Signaling Technology Inc, Merck KGaA, Bio-Techne Corporation, Affymetrix, Danaher Corporation, Miltenyi Biotec, R&D Systems, Siemens Healthineers, F Hoffmann-La Roche Ltd, Sartorius, Sysmex Corporation, Nihon Kohden Corporation, Diasorin SpA, Janssen Diagnostics.
North America was the largest region in the cell surface marker detection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell surface marker detection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell surface marker detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cell surface marker detection market by increasing costs of imported flow cytometers, hematology analyzers, antibodies, reagents, and electronic components. Research institutions and diagnostic laboratories in North America and Europe are most affected due to dependence on imported analytical instruments, while Asia-Pacific faces higher reagent and equipment costs. These tariffs are increasing laboratory operating expenses and slowing equipment upgrades. At the same time, they are supporting regional manufacturing of reagents, local instrument assembly, and domestic innovation in analytical technologies.
The cell surface marker detection market research report is one of a series of new reports that provides cell surface marker detection market statistics, including cell surface marker detection industry global market size, regional shares, competitors with a cell surface marker detection market share, detailed cell surface marker detection market segments, market trends and opportunities, and any further data you may need to thrive in the cell surface marker detection industry. This cell surface marker detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell surface marker detection involves the classification of cells based on their markers, which are proteins expressed on the cell surface or carbohydrates linked to the cell membrane. These markers serve as unique identifiers for specific cell types, akin to fingerprints. This process is valuable for categorizing cells based on their distinct markers.
The primary products associated with cell surface marker detection include flow cytometry, hematology analyzers, and various reagents and kits. Flow cytometry is a laboratory test that analyzes the properties of cells or particles suspended in fluid. During the procedure, a sample is injected into a flow cytometer machine, and a computer can rapidly evaluate and process a large number of cells. Flow cytometry is commonly used to assess bone marrow, peripheral blood, and other bodily fluids, playing a crucial role in disease diagnosis, diseases identification, drug discovery research, and cytological academic research. These products are utilized by a range of entities, including pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, academic and research institutes, among others. They contribute significantly to advancements in medical research, diagnostics, and drug development.
The cell surface marker detection market consists of revenues earned by entities by providing cell surface marker detection services such as cell analysis, fluorescence-activated cell sorting (FACS) analysis, immunohistochemistry, blood test, Tbnk test. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell surface marker detection market also includes sales of kits, dyes, analyzers equipment which are used in providing cell surface marker detection services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cell Surface Marker Detection Market Characteristics
3. Cell Surface Marker Detection Market Supply Chain Analysis
4. Global Cell Surface Marker Detection Market Trends and Strategies
5. Cell Surface Marker Detection Market Analysis of End Use Industries
7. Global Cell Surface Marker Detection Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cell Surface Marker Detection Total Addressable Market (TAM) Analysis for the Market
9. Cell Surface Marker Detection Market Segmentation
10. Cell Surface Marker Detection Market Regional and Country Analysis
11. Asia-Pacific Cell Surface Marker Detection Market
12. China Cell Surface Marker Detection Market
13. India Cell Surface Marker Detection Market
14. Japan Cell Surface Marker Detection Market
15. Australia Cell Surface Marker Detection Market
16. Indonesia Cell Surface Marker Detection Market
17. South Korea Cell Surface Marker Detection Market
18. Taiwan Cell Surface Marker Detection Market
19. South East Asia Cell Surface Marker Detection Market
20. Western Europe Cell Surface Marker Detection Market
21. UK Cell Surface Marker Detection Market
22. Germany Cell Surface Marker Detection Market
23. France Cell Surface Marker Detection Market
24. Italy Cell Surface Marker Detection Market
25. Spain Cell Surface Marker Detection Market
26. Eastern Europe Cell Surface Marker Detection Market
27. Russia Cell Surface Marker Detection Market
28. North America Cell Surface Marker Detection Market
29. USA Cell Surface Marker Detection Market
30. Canada Cell Surface Marker Detection Market
31. South America Cell Surface Marker Detection Market
32. Brazil Cell Surface Marker Detection Market
33. Middle East Cell Surface Marker Detection Market
34. Africa Cell Surface Marker Detection Market
36. Cell Surface Marker Detection Market Competitive Landscape and Company Profiles
37. Cell Surface Marker Detection Market Other Major and Innovative Companies
40. Cell Surface Marker Detection Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cell Surface Marker Detection Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cell surface marker detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell surface marker detection? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell surface marker detection market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Flow Cytometry; Reagents And Kits2) By Application: Disease Diagnosis; Diseases Identification; Research For Drug Discovery; Cytological Academic Research
3) By End-Users: Pharmaceutical And Biotechnology Companies; Hospitals And Clinical Testing Laboratories; Academic And Research Institutes; Other End Users
Subsegments:
1) By Flow Cytometry: Benchtop Flow Cytometers; Portable Flow Cytometers; High-Throughput Flow Cytometers2) By Reagents And Kits: Antibodies And Conjugates; Staining Kits; Calibration And Control Kits
Companies Mentioned: Thermo Fisher Scientific Inc; Beckman Coulter Inc; Bio-Rad Laboratories Inc; Becton Dickinson and Company; BD Biosciences; Agilent Inc; Sigma-Aldrich; Qiagen NV; Abcam PLC; GenScript Biotech; BioLegend; Cell Signaling Technology Inc; Merck KGaA; Bio-Techne Corporation; Affymetrix; Danaher Corporation; Miltenyi Biotec; R&D Systems; Siemens Healthineers; F Hoffmann-La Roche Ltd; Sartorius; Sysmex Corporation; Nihon Kohden Corporation; Diasorin SpA; Janssen Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cell Surface Marker Detection market report include:- Thermo Fisher Scientific Inc
- Beckman Coulter Inc
- Bio-Rad Laboratories Inc
- Becton Dickinson and Company
- BD Biosciences
- Agilent Inc
- Sigma-Aldrich
- Qiagen NV
- Abcam PLC
- GenScript Biotech
- BioLegend
- Cell Signaling Technology Inc
- Merck KGaA
- Bio-Techne Corporation
- Affymetrix
- Danaher Corporation
- Miltenyi Biotec
- R&D Systems
- Siemens Healthineers
- F Hoffmann-La Roche Ltd
- Sartorius
- Sysmex Corporation
- Nihon Kohden Corporation
- Diasorin SpA
- Janssen Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.11 Billion |
| Forecasted Market Value ( USD | $ 10.81 Billion |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
